Lactobacillus rhamnosus Probiotic - 200 Billion CFU | Clinically Proven for Gut & Immune Health
Lactobacillus rhamnosus is an anaerobic, acid-resistant, non-spore-forming Gram-positive probiotic. It possesses biological characteristics such as acid tolerance, bile salt resistance, and resistance to multiple antibiotics. Our product is made from Lactobacillus rhamnosus using a high-density cultivation fermentation process and low-temperature freeze-drying protection technology. The freeze-dried bacterial powder includes the strain, protective agent, and diluent carriers.
Key Advantages
Exceptional Survival
Survival rate of ≥95% in gastric acid environment with pH 2.5.
Precise Colonization
Intestinal retention time of up to 14 days (compared to 3-5 days for regular strains).
Stability Guarantee
Live bacteria remain stable for 24 months at room temperature.
Why choose our Lactobacillus rhamnosus strain?
Our L. rhamnosus has been validated through 5 clinical trials and offers the following unique advantages
Improvement in antibiotic-associated diarrhea, reduction in the duration of rotavirus diarrhea in children, recurrent urinary tract infections (UTIs) in women and eczema symptoms in infants.
Industry-Leading Survival Technology
Third-generation microencapsulation + freeze-drying protection technology.
Full-Link Transparent Traceability
China Industrial Microorganism Strain Preservation Center CICC number, GMP standardized production, SGS third-party live bacteria count verification, and full-process temperature control.
Applications
Dietary Supplements-enteric-coated capsules / chewable tablets / powder: Improve antibiotic-associated diarrhea, relieve IBS symptoms.
Infant Nutrition-drops / formula milk: Prevent rotavirus diarrhea, alleviate infant eczema symptoms.
Women's Health Products-oral capsules / vaginal suppositories: Prevent urinary tract infection (UTI) recurrence, maintain vaginal microbiota balance.
Functional Foods-probiotic chocolate, ready-to-eat probiotic cereal bars.
Oral Care-probiotic toothpaste / mouthwash, oral probiotic lozenges.
Scientific Clinical Research
Diarrhea Relief
89% improvement in antibiotic-associated diarrhea
1.8-day reduction in the duration of rotavirus diarrhea in children
Immune Enhancement
37% reduction in respiratory infections in children (8-week clinical study)
42% increase in vaccine antibody response
Women's Health
50% reduction in urinary tract infection recurrence
62% relief in bacterial vaginosis symptoms
Gut Barrier
35% increase in tight junction protein expression (ZO-1↑)
51% reduction in intestinal permeability (mannitol ratio↓)
Skin Health
42% improvement in infant atopic dermatitis symptoms (12-week study)
Technical Specifications
|
Strain Name |
Lactobacillus rhamnosus NSL0401 |
|
Viable Count |
≥2×1011 CFU/g |
|
Moisture |
≤5.0% |
|
Packing |
500g/bag, 1kg/bag, 5kg/bag or customized |
Production Process
FAQ
Hot Tags: lactobacillus rhamnosus, China lactobacillus rhamnosus manufacturers, suppliers, factory, fermenti lattici saccharomyces boulardii e lactobacillus rhamnosus gg, lactobacillus rhamnosus l jensenii l crispatus l gasseri oral supplement, cepa 35624 de bifidobacterium longum, lactobacillus gasseri vaginal, l gasseri probiotic, probiotics for human use
